Robot vs. electromagnetic navigation: which lung biopsy method wins?
NCT ID NCT06654271
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 34 times
Summary
This study compares two advanced bronchoscopy techniques—robotic assisted and electromagnetic navigation—to see which one better obtains tissue from lung lesions. About 440 adults scheduled for a lung biopsy will be randomly assigned to one method. The main goal is to measure how often each method successfully collects diagnostic tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL PULMONARY LESION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If one method proves clearly better, it could become the standard way to biopsy lung lesions, improving diagnosis accuracy.
What could go wrong
This is a pragmatic trial comparing two existing devices, not a new treatment. The difference in diagnostic yield may be small or not clinically meaningful.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.